Drug Shortage Report for LOZIDE

Last updated on 2020-10-12 History
Report ID 120926
Drug Identification Number 02179709
Brand name LOZIDE
Common or Proper name lozide
Company Name SERVIER CANADA INC
Market Status MARKETED
Active Ingredient(s) INDAPAMIDE
Strength(s) 1.25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code C03BA
ATC description LOW-CEILING DIURETICS, EXCL THIAZIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-08-24
Actual start date 2020-08-24
Estimated end date 2020-10-13
Actual end date 2020-10-09
Shortage status Resolved
Updated date 2020-10-12
Company comments
Health Canada comments
Contact Address 235 BOUL. ARMAND-FRAPPIER - PARC SCIENTIF. ET DE HAUTE TECH. DE LAVAL
LAVAL, QUEBEC
CANADA H7V 4A7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2020-10-12 French Compare
v15 2020-10-12 English Compare
v14 2020-10-06 French Compare
v13 2020-10-06 English Compare
v12 2020-10-06 English Compare
v11 2020-10-01 French Compare
v10 2020-10-01 English Compare
v9 2020-08-25 English Compare
v8 2020-08-24 French Compare
v7 2020-08-24 English Compare
v6 2020-08-12 French Compare
v5 2020-08-12 English Compare
v4 2020-08-06 English Compare
v3 2020-07-23 French Compare
v2 2020-07-23 English Compare
v1 2020-07-23 English Compare